[en] A 51-year-old Caucasian woman developed severe drug-induced toxic epidermal necrolysis (TEN) due to allopurinol. The withdrawal of the culprit drug was unfortunately delayed, and dramatic retardation of reepithelialization was observed. At that stage of disease evolution, an inflammatory cell infiltrate was present in the dermis. Coverage of eroded lesions by frozen cultured keratinocyte allografts failed to hasten reepithelialization compared to ungrafted sites. This unusual protracted TEN evolution was followed by the development of extensive hypertrophic and keloid scars. Several biopsies were taken over 6 months. The histologic presentation of the grafted and ungrafted eroded scar tissues looked similar. Both the number and size of the Factor XIIIa-positive dermal dendrocytes, as well as the number of alpha-actin-positive myofibroblasts showed a marked increase between weeks 2 and 12 after grafting. They were reduced after 6 months when the scarring process was stabilized. alpha1 [IV] collagen was never expressed over the eroded scars. Similar to burn patients, delayed reepithelialization might be a risk factor for abnormal scarring in TEN. Cultured keratinocyte allograft apparently offered no improvement in reepithelialization and did not prevent abnormal scarring in this TEN patient.
Disciplines :
Dermatology
Author, co-author :
Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Jacob, E.; Centre Hospitalier Universitaire de Liège - CHU
Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Jacquemin, Denise ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie maxillo-faciale et plastique
Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis.
Publication date :
2007
Journal title :
Burns: Journal of the International Society for Burn Injuries
Fritsch P.O., and Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 1 (2000) 349-360
Paquet P., Paquet F., Al Saleh W., Reper P., Vanderkelen A., and Pierard G.E. Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis. Am J Dermatopathol 22 (2000) 413-417
Lim I.J., Phan T.T., Bay B.H., Qi R., Huynh H., Tan W.T., et al. Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloid like manner. Am J Physiol Cell Physiol 283 (2002) C212-C222
Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200 (2003) 500-503
Quatresooz P., Henry F., Paquet P., Pierard-Franchimont C., Harding K., and Pierard G.E. Deciphering the impaired cytokine cascades in chronic leg ulcers. Int J Mol Med 11 (2003) 411-418
Machesney M., Tidman N., Waseem A., Kirby L., and Leigh I. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 152 (1998) 1133-1141
Lim I.J., Phan T.T.P., and Song C. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 107 (2001) 797-808
Niessen F.B., Spauwen P.H., Schalkwijk, and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 105 (1999) 1435-1458
Funayama E., Chodon T., Oyama A., and Sugihara T. Keratinocytes provide proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. J Invest Dermatol 121 (2003) 1326-1331
Hermanns-Lê T., and Piérard G.E. Factor XIIIa-positive dendrocyte rarefaction in Ehlers-Danlos syndrome, classic type. Am J Dermatopathol 23 (2001) 427-430
Quatresooz P., Hermanns-Lê T., Ciccarelli A., Beckers A., and Pierard G.E. Tensegrity and type I dermal dendrocytes in acromegaly. Eur J Clin Invest 35 (2005) 133-139
Hermanns-Lê T., Paquet P., Piérard-Franchimont C., Arrese J.E., and Piérard G.E. Regulatory function of factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. Dermatology 198 (1999) 184-186
Kavanagh G.M., Page P., and Hanna M.M. Silicone gel treatment of extensive hypertrophic scarring following toxic epidermal necrolysis. Br J Dermatol 130 (1994) 540-541
Bhashan M., Brooke R., Hewitt-Symond S.M., et al. Prolonged toxic epidermal necrolysis due to lamotrigine. Clin Exp Dermatol 25 (2000) 349-354
Paquet P., Vanderkelen A., Gielen V., and Lapière ChM. The skin equivalent: its use in vivo. Cytotechnology 50 (1989) S47-S53
Burd A., and Chan E. Keratinocyte-keloid interaction. Plast Reconstr Surg 110 (2002) 197-202
Klein L., Mericka P., Strakova H., Jebavy L., Nozickova M., Blaha M., et al. Biological skin covers in treatment of two cases of the Lyell's syndrome. Ann Transplant 2 (1997) 45-48
Paquet P., Quatresooz P., Braham C., and Piérard G.E. Tapping into the influence of keratinocyte allografts and biocenosis on healing of chronic leg ulcers: split-ulcer controlled pilot study. Dermatol Surg 31 (2005) 431-435